Cerebrovascular accident
|
0.500 |
GeneticVariation
|
group |
BEFREE |
No apparent association between the VNTR genotype and plasma lipid concentration was observed; however, for the same genotype, the CAD and stroke patients frequently showed higher lipoprotein(a) and lower HDL cholesterol concentrations than the control group.
|
8665685 |
1996 |
Cerebrovascular accident
|
0.500 |
GeneticVariation
|
group |
BEFREE |
Multiple regression analyses for all subjects (n=90) showed that being a stroke patient (p<0.0001), fibrinogen (p<0.0001) and lipoprotein(a) (p=0.0075) were independent predictors of clot permeability (model R2 0.79).
|
19942259 |
2010 |
Cerebrovascular accident
|
0.500 |
Biomarker
|
group |
BEFREE |
The comparable strength of associations of the LPA score with coronary disease and peripheral vascular disease but not with stroke suggest that lipoprotein(a) may have effects on atherothrombotic vascular disease that are only relevant at specific sites.
|
21252144 |
2011 |
Cerebrovascular accident
|
0.500 |
Biomarker
|
group |
BEFREE |
Levels of LDL corrected for lipoprotein(a) were an even stronger predictor of dementia with stroke in the adjusted multivariate analysis.
|
10422994 |
1999 |
Cerebrovascular accident
|
0.500 |
Biomarker
|
group |
BEFREE |
We report apolipoprotein(a) (apo(a)) phenotypes of 69 myocardial infarction survivors and 56 stroke patients, and compare them with those of 190 healthy Chinese.
|
8187226 |
1994 |
Cerebrovascular accident
|
0.500 |
Biomarker
|
group |
BEFREE |
Antisense oligonucleotide therapy has shown some promise in treating stroke causes that are genetically determined and resistant to classic prevention approaches such as elevated lipoprotein (a) and cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL).
|
30635869 |
2019 |
Cerebrovascular accident
|
0.500 |
Biomarker
|
group |
BEFREE |
Lipoprotein (a) and stroke.
|
10961170 |
2000 |
Cerebrovascular accident
|
0.500 |
Biomarker
|
group |
BEFREE |
Lipoprotein(a) and other ASCVD risk factors were measured at baseline (1996-1998) in the biracial Atherosclerosis Risk in Communities study; participants without prevalent ASCVD (coronary heart disease or stroke) were monitored ∼15 years for incident ASCVD events.
|
30685442 |
2019 |
Cerebrovascular accident
|
0.500 |
GeneticVariation
|
group |
BEFREE |
In this cross-sectional study we compared the abilities of lipoprotein(a) [Lp(a)], plasminogen activator inhibitor-1 (PAI-1), and tissue plasminogen activator (TPA) to discriminate between individuals with and without a history of stroke from among subjects in a metabolic ward.
|
8548412 |
1996 |
Cerebrovascular accident
|
0.500 |
Biomarker
|
group |
BEFREE |
Valproic acid can increase lipoprotein(a) and decrease fibrinogen, which may increase the risk of stroke or other thrombotic events.
|
19135623 |
2009 |
Cerebrovascular accident
|
0.500 |
GeneticVariation
|
group |
BEFREE |
Various prothrombotic risk factors have been investigated in pediatric stroke including elevated homocysteine and lipoprotein (a), antithrombin, protein C and protein S deficiency, Factor V Leiden, Factor II G20210A and plasminogen activator inhibitor-1 4G/5G polymorphism.
|
23092062 |
2012 |
Cerebrovascular accident
|
0.500 |
Biomarker
|
group |
BEFREE |
High plasma concentrations of lipoprotein(a) [Lp(a), which is encoded by the APOA gene] increase an individual's risk of developing diseases, such as coronary artery diseases, restenosis, and stroke.
|
21804189 |
2011 |
Cerebrovascular accident
|
0.500 |
Biomarker
|
group |
BEFREE |
High concentrations of plasma lipoprotein(a) [Lp(a)] have been inferred to be an independent risk factor for cardiovascular and cerebrovascular diseases, such as coronary artery diseases, restenosis, and stroke.
|
29064597 |
2018 |
Cerebrovascular accident
|
0.500 |
Biomarker
|
group |
BEFREE |
Most children with pediatric stroke have more than one risk factor, mainly vasculopathies or elevation of lipoprotein(a).
|
17675027 |
2007 |
Cerebrovascular accident
|
0.500 |
GeneticVariation
|
group |
BEFREE |
Lipoprotein(a) [Lp(a)] is an established risk factor for coronary disease and stroke, but mechanisms underlying this association are unknown.
|
21078622 |
2011 |
Cerebrovascular accident
|
0.500 |
GeneticVariation
|
group |
BEFREE |
Lipoprotein(a) Lp(a) is a cholesterol-rich, LDL-like particle that is independently associated with an increased risk for ischemic heart disease, atherosclerosis, thrombosis, and stroke.
|
28608522 |
2018 |
Cerebrovascular accident
|
0.500 |
Biomarker
|
group |
BEFREE |
In 269 primary schoolchildren aged 6-11 years (145 boys and 124 girls) we measured the blood concentrations of total cholesterol, apolipoproteins B and A-1, and lipoprotein(a), and questioned their parents about coronary or cerebral vascular events.
|
9133253 |
1997 |
Cerebrovascular accident
|
0.500 |
Biomarker
|
group |
BEFREE |
Serum lipoprotein(a) and risk of hemorrhagic stroke among incident peritoneal dialysis patients: a large study from a single center in China.
|
31498021 |
2019 |
Cerebrovascular accident
|
0.500 |
Biomarker
|
group |
BEFREE |
Elevated lipoprotein (a) [LP (a)] concentrations are independent risk factors of coronary heart disease or stroke in young adults.
|
9164807 |
1997 |
Cerebrovascular accident
|
0.500 |
AlteredExpression
|
group |
BEFREE |
Higher prevalences of hypertension, diabetes, obesity (in women), elevated lipoprotein(a) level, smoking (in men), and low socioeconomic status may contribute to the higher stroke incidence and mortality in US Blacks as compared with Whites.
|
10604768 |
1999 |
Cerebrovascular accident
|
0.500 |
GeneticVariation
|
group |
BEFREE |
Increased levels of lipoprotein(a) (Lp[a])are known independent risk factor for atherosclerosis, heart disease, and stroke in adults.
|
22187404 |
2011 |
Cerebrovascular accident
|
0.500 |
GeneticVariation
|
group |
BEFREE |
Previous studies have examined the association of lipoprotein(a) and risk of stroke; however, the results are conflicting.
|
31272552 |
2019 |
Cerebrovascular accident
|
0.500 |
GeneticVariation
|
group |
BEFREE |
One hundred forty-eight Caucasian infants and children (aged 0.5 to 16 years) with stroke and 296 age-matched controls from the same geographic areas as the patients were analyzed for increased lipoprotein (a) [Lp(a)] levels >30 mg/dL; for the presence of the factor V (FV) G1691A mutation, the prothrombin (PT) G20210A variant, and the TT677 genotype of methylenetetrahydrofolate reductase (MTHFR); and deficiencies of protein C, protein S, and antithrombin.
|
10572079 |
1999 |
Cerebrovascular accident
|
0.500 |
Biomarker
|
group |
BEFREE |
Raised lipoprotein (a), protein C deficiency, and stroke of vascular origin are risk factors for recurrent arterial ischaemic stroke in childhood.
|
12443591 |
2002 |
Cerebrovascular accident
|
0.500 |
GeneticVariation
|
group |
BEFREE |
Serum lipoprotein (a) is associated with increased risk of stroke in Chinese adults: A prospective study.
|
31437611 |
2019 |